Sana Biotechnology, Inc.
For the period ended Mar 31, 2026. Filed May 11, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 11, 2026
SANA$2.43-1.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
8. Property and equipment, net
Property and equipment, net consists of the following:
| March 31, 2026 | December 31, 2025 | |
|---|---|---|
| (in thousands) | ||
| Laboratory equipment | $39,602 | $38,462 |
| Leasehold improvements | 39,061 | 39,061 |
| Computer equipment, software, and other | 4,156 | 4,138 |
| Total property and equipment, at cost | 82,819 | 81,661 |
| Less: Accumulated depreciation | (57,146) | (54,755) |
| Property and equipment, net | $25,673 | $26,906 |
Depreciation expense was $2.4 million and $3.6 million for the three months ended March 31, 2026 and 2025, respectively.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.